| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 01/10/2023 | Jounce Therapeutics, Inc. | JNCE | Sale | Common Stock | 9.2k | $1.12 | $10.3k | | 01/09/2023 |
| 01/09/2023 | Jounce Therapeutics, Inc. | JNCE | Sale | Common Stock | 7.5k | $1.10 | $8.2k | | 01/09/2023 |
| 08/01/2022 | Jounce Therapeutics, Inc. | JNCE | Grant | Common Stock | 20k | $0.00 | $0 | | 08/01/2022 |
| 08/01/2022 | Jounce Therapeutics, Inc. | JNCE | Grant | Stock Option (Right to Buy) | 40k | $2.97 | $118.8k | | 08/01/2022 |
| 06/09/2022 | Astria Therapeutics, Inc. | ATXS | Grant | Stock Option (right to buy) | 8.3k | $2.99 | $24.9k | | 06/09/2022 |
| 06/09/2022 | Astria Therapeutics, Inc. | ATXS | Grant | Stock Option (right to buy) | 8.3k | $0.00 | $0 | | 06/09/2022 |
| 02/01/2022 | Jounce Therapeutics, Inc. | JNCE | Grant | Common Stock | 42.5k | $0.00 | $0 | | 02/01/2022 |
| 02/01/2022 | Jounce Therapeutics, Inc. | JNCE | Grant | Stock Option (Right to Buy) | 85k | $7.56 | $642.6k | | 02/01/2022 |
| 02/01/2022 | Jounce Therapeutics, Inc. | JNCE | Grant | Stock Option (Right to Buy) | 85k | $7.56 | $642.6k | | 02/01/2022 |
| 01/10/2022 | Jounce Therapeutics, Inc. | JNCE | Sale | Common Stock | 6.2k | $6.65 | $41.3k | | 01/07/2022 |
| 01/07/2022 | Jounce Therapeutics, Inc. | JNCE | Sale | Common Stock | 3.5k | $7.30 | $25.3k | | 01/07/2022 |
| 06/02/2021 | Astria Therapeutics, Inc. | ATXS | Grant | Stock Option (right to buy) | 100k | $2.04 | $204k | | 06/02/2021 |
| 02/01/2021 | Jounce Therapeutics, Inc. | JNCE | Grant | Stock Option (Right to Buy) | 53.4k | $11.89 | $634.9k | | 02/01/2021 |
| 02/01/2021 | Jounce Therapeutics, Inc. | JNCE | Grant | Common Stock | 26.7k | $0.00 | $0 | | 02/01/2021 |
| 01/22/2021 | Jounce Therapeutics, Inc. | JNCE | Sale | Common Stock | 18k | $11.95 | $215.1k | | 01/22/2021 |
| 01/22/2021 | Jounce Therapeutics, Inc. | JNCE | Exercise | Stock Option (Right to Buy) | 5k | $4.40 | $22k | | 01/22/2021 |
| 01/22/2021 | Jounce Therapeutics, Inc. | JNCE | Exercise | Stock Option (Right to Buy) | 5k | $6.55 | $32.8k | | 01/22/2021 |
| 01/08/2021 | Jounce Therapeutics, Inc. | JNCE | Sale | Common Stock | 3.3k | $7.00 | $23.4k | | 01/07/2021 |
| 01/07/2021 | Jounce Therapeutics, Inc. | JNCE | Sale | Common Stock | 2.9k | $6.76 | $19.5k | | 01/07/2021 |
| 08/18/2020 | Jounce Therapeutics, Inc. | JNCE | Sale | Common Stock | 744 | $4.71 | $3.5k | | 08/14/2020 |
| 08/17/2020 | Jounce Therapeutics, Inc. | JNCE | Sale | Common Stock | 454 | $4.86 | $2.2k | | 08/14/2020 |
| 08/14/2020 | Jounce Therapeutics, Inc. | JNCE | Sale | Common Stock | 984 | $4.64 | $4.6k | | 08/14/2020 |
| 06/11/2020 | Astria Therapeutics, Inc. | ATXS | Grant | Stock Option (right to buy) | 7.5k | $6.17 | $46.3k | | 06/11/2020 |
| 02/03/2020 | Jounce Therapeutics, Inc. | JNCE | Grant | Common Stock | 30k | $0.00 | $0 | | 02/03/2020 |
| 02/03/2020 | Jounce Therapeutics, Inc. | JNCE | Grant | Common Stock | 60k | $6.55 | $393k | | 02/03/2020 |
| 01/07/2020 | Jounce Therapeutics, Inc. | JNCE | Sale | Common Stock | 2.6k | $7.78 | $20.4k | | 01/07/2020 |
| 08/16/2019 | Jounce Therapeutics, Inc. | JNCE | Sale | Common Stock | 1k | $3.92 | $4k | | 08/14/2019 |
| 08/15/2019 | Jounce Therapeutics, Inc. | JNCE | Sale | Common Stock | 648 | $4.00 | $2.6k | | 08/14/2019 |
| 08/14/2019 | Jounce Therapeutics, Inc. | JNCE | Sale | Common Stock | 670 | $4.10 | $2.7k | | 08/14/2019 |
| 07/26/2019 | Astria Therapeutics, Inc. | ATXS | Grant | Stock Option (right to buy) | 15k | $6.82 | $102.3k | | 07/26/2019 |
| 02/01/2019 | Jounce Therapeutics, Inc. | JNCE | Grant | Common Stock | 22.2k | $0.00 | $0 | | 02/01/2019 |
| 02/01/2019 | Jounce Therapeutics, Inc. | JNCE | Grant | Stock Option (Right to Buy) | 44.5k | $4.40 | $195.8k | | 02/01/2019 |
| 08/13/2018 | Jounce Therapeutics, Inc. | JNCE | Grant | Common Stock | 14.4k | $0.00 | $0 | | 08/13/2018 |
| 06/15/2018 | Jounce Therapeutics, Inc. | JNCE | Purchase | Common Stock | 1.9k | $7.84 | $14.9k | | 06/15/2018 |
| 02/01/2018 | Jounce Therapeutics, Inc. | JNCE | Grant | Stock Option (Right to Buy) | 70.5k | $23.98 | $1.7M | | 02/01/2018 |
|